satralizumab
Showing 1 - 10 of 10
Thyroid Eye Disease Trial (Satralizumab, Placebo)
Not yet recruiting
- Thyroid Eye Disease
- Satralizumab
- Placebo
- (no location specified)
Oct 25, 2023
Thyroid Eye Disease Trial (Satralizumab, Placebo)
Not yet recruiting
- Thyroid Eye Disease
- Satralizumab
- Placebo
- (no location specified)
Aug 4, 2023
Aneurysmal Subarachnoid Hemorrhage, Delayed Cerebral Ischemia Trial in Gainesville (Satralizumab)
Not yet recruiting
- Aneurysmal Subarachnoid Hemorrhage
- Delayed Cerebral Ischemia
- Satralizumab
-
Gainesville, FloridaUniversity of Florida (UF) Health Shands Hospital
Feb 13, 2023
Neuromyelitis Optica Spectrum Disorder, NMOSD Trial in Le Kremlin-bicĂȘtre, Gdansk (Satralizumab)
Recruiting
- Neuromyelitis Optica Spectrum Disorder
- NMOSD
- Satralizumab
-
Le Kremlin-bicĂȘtre, France
- +1 more
Aug 17, 2022
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) Trial in Germany, Italy, United States (Satralizumab,
Recruiting
- Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)
- Satralizumab
- Placebo
-
Washington, District of Columbia
- +3 more
Aug 2, 2022
NMDAR Autoimmune Encephalitis, LGI1 Autoimmune Encephalitis Trial in Prague, Praha 5 (Satralizumab, Placebo)
Not yet recruiting
- NMDAR Autoimmune Encephalitis
- LGI1 Autoimmune Encephalitis
- Satralizumab
- Placebo
-
Prague, Czechia
- +1 more
Aug 15, 2022
Neuromyelitis Optica (NMO), NMO Spectrum Disorder (NMOSD) Trial in Worldwide (Satralizumab, Placebo, Baseline Treatment)
Completed
- Neuromyelitis Optica (NMO)
- NMO Spectrum Disorder (NMOSD)
- Satralizumab
- +2 more
-
Birmingham, Alabama
- +38 more
Jan 24, 2022
Neuromyelitis Optica Spectrum Disorder Trial in Worldwide (satralizumab, azathioprine (AZA), mycophenolate mofetil (MMF))
Active, not recruiting
- Neuromyelitis Optica Spectrum Disorder
- satralizumab
- +3 more
-
Birmingham, Alabama
- +52 more
Mar 16, 2022
Neuromyelitis Optica (NMO), NMO Spectrum Disorder (NMOSD) Trial in Worldwide (Satralizumab, Placebo)
Completed
- Neuromyelitis Optica (NMO)
- NMO Spectrum Disorder (NMOSD)
- Satralizumab
- Placebo
-
Aurora, Colorado
- +57 more
Feb 11, 2022
Generalized Myasthenia Gravis Trial in Worldwide (Satralizumab, Placebo)
Recruiting
- Generalized Myasthenia Gravis
- Satralizumab
- Placebo
-
Scottsdale, Arizona
- +94 more
Aug 16, 2022